Valeant Pharma Turns To Profit In Q4, But Revenues Miss View

Valeant Pharmaceuticals International, Inc. (VRX, VRX.TO) on Wednesday reported a turnaround to profit in the fourth quarter, reflecting a tax benefit that helped offset lower revenues.

from RTT - Earnings http://ift.tt/2Cqj9GT
via IFTTT